Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
about
MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP functionTumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53Mutational analysis of an RNA polymerase II elongation factor in Drosophila melanogasterFlt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner.Chromosomal translocations involving the MLL gene: molecular mechanisms.Regulation of fertility, survival, and cuticle collagen function by the Caenorhabditis elegans eaf-1 and ell-1 genes.ALL-1/MLL1, a homologue of Drosophila TRITHORAX, modifies chromatin and is directly involved in infant acute leukaemia.TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells.Large-scale identification of disease genes involved in acute myeloid leukemiaMolecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents.Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.The molecular biology of mixed lineage leukemia.Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response.Multiple mixed lineage leukemia (MLL) fusion proteins suppress p53-mediated response to DNA damage.ELL inhibits E2F1 transcriptional activity by enhancing E2F1 deacetylation via recruitment of histone deacetylase 1.Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors.
P2860
Q24557551-65635CCE-69A4-4108-AF08-727BE3819DFBQ33604141-982730C0-7FE0-4BDB-8B31-7EDB64B70913Q33925022-04B8DAAB-2366-4BCA-80DE-5EE4036AB58AQ34709391-04E72CA0-09B4-422E-944C-0A3AD5DAE241Q35128590-384D95DC-38EC-4FD7-A33C-6FF925D67C14Q35372544-F2B0F06E-469C-4FE6-A105-3A10589F872AQ35670201-7EBD3873-1151-43F0-A880-9C1097440C34Q35960563-B51C6B08-229D-4E04-BEDA-DB1CD420C54CQ36959992-98B8E58F-8948-4516-8A33-B71CE36BD45AQ37260555-2F7EC66B-CC47-44EC-AAF4-25E68BAD5916Q37330859-4888F622-1FA2-4716-821A-EC4278D20144Q37522825-A2FCE290-74CC-4DE8-9A43-A1B36E8D91D6Q38642087-AC5698C5-C261-4F5C-8905-8606CA1962B7Q40430768-FFF6D5CB-8549-4F56-A065-0EB1DF11E5EAQ41908759-6596C114-D88A-4145-ABEA-26920EA26059Q43099231-AE3B6D44-BDF3-4FDA-A94F-69CF1B9F067EQ53075287-F4B877F8-AC44-4A7D-9A98-E25C4E2C9D81
P2860
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
@ast
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
@en
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
@nl
type
label
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
@ast
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
@en
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
@nl
prefLabel
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
@ast
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
@en
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
@nl
P2093
P2860
P3181
P1476
Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
@en
P2093
Dmitri Wiederschain
Hidehiko Kawai
Zhi-Min Yuan
P2860
P304
P3181
P356
10.1128/MCB.23.12.4230-4246.2003
P407
P577
2003-06-01T00:00:00Z